Company
Nevro Corp.
Headquarters: Redwood City, CA, United States
Employees: 945
CEO: Mr. D. Keith Grossman
Market Cap
$190.4 Million
USD as of Jan. 1, 2025
Nevro Corp. Categories
United States Healthcare Medical DevicesUnited States Healthcare United States Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Financials
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | $425.2 M |
| EBITDA | $-92,258,000 |
| Gross Profit TTM | $290.1 M |
| Profit Margin | -21.69% |
| Operating Margin | -10.15% |
| Quarterly Revenue Growth | 2.00% |
Stocks & Indices
Nevro Corp. has the following listings and related stock indices.
Stock: NYSE: NVRO wb_incandescent
Stock: FSX: 1N7 wb_incandescent